2010-11-23 00:00:00,Gilead Submits New Drug Application To FDA For Regimen Of Truvada And TMC278 For HIV
2010-12-20 00:00:00,Gilead To Acquire Arresto Biosciences For Million
2010-12-22 00:00:00,Gilead Terminates Phase III Clinical Trial Of Ambrisentan In Patients With Idiopathic Pulmonary Fibrosis
2011-02-10 00:00:00,Gilead Refiles New Drug Application With FDA For Regimen of Truvada
2011-02-22 00:00:00,Gilead To Acquire Calistoga Pharmaceuticals For Million
2011-04-20 00:00:00,Gilead And MicroDose Therapeutx Announce License And Collaboration Agreement To Develop For Treatment Of Respiratory Syncytial Virus
2011-08-08 00:00:00,Gilead To Purchase Biologics Process Research And Clinical Manufacturing Facility From Genentech
2011-08-10 00:00:00,Food and Drug Administration Approves Gilead Complera
2011-08-15 00:00:00,Gilead Announces Result Of Phase 3 Clinical Trial Of Investigational Antiretroviral Quad Regimen
2011-11-15 00:00:00,Gilead Finalizes Agreement With Tibotec Pharmaceuticals To Develop And Commercialize Regimen Of Prezista With Emtriva
2011-11-21 00:00:00,Gilead to Acquire for Billion
2011-11-28 00:00:00,Gilead Receives European Marketing Authorization for Eviplera
2011-12-09 00:00:00,Gilead Announces Data From Pivotal Phase 3 Study Of Elvitegravir
2011-12-15 00:00:00,Gilead Submits Supplemental New Drug Application To Food And Drug Administration For Truvada For Reducing Risk Of Acquiring HIV
2011-12-20 00:00:00,Gilead Files European Marketing Application For Quad
2011-12-22 00:00:00,JAPAN TOBACCO Signs License Contract for Cobicistat
2012-02-17 00:00:00,Gilead Announces Data For Genotype 1 Null Responder Hepatitis C Patients Enrolled In ELECTRON Study
2012-03-09 00:00:00,Data Show Gilead Quad Regimen For HIV To Regimen At 48 Weeks In Second Pivotal Phase 3 Study
2012-10-23 00:00:00,Gilead Sciences Inc Raises FY 2012 Product Sales Call
2012-10-25 00:00:00,Buy Gilead HIV And Hepatitis Drugs To Drive Growth
2012-10-26 00:00:00,Research Weekly Ratings Changes for Gilead Sciences
2012-10-31 00:00:00,Gilead Sciences Inc Phase 2 Clinical Trial Evaluating Tenofovir Alafenamide Fumarate Met Its Primary Objective
2012-11-02 00:00:00,Vanguard Health Care Fund Does More Shedding than Adding in Third Quarter
